financetom
Business
financetom
/
Business
/
Allarity Therapeutics Says FDA Granted Fast-Track Designation to Stenoparib; Shares Rise Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Allarity Therapeutics Says FDA Granted Fast-Track Designation to Stenoparib; Shares Rise Pre-Bell
Aug 26, 2025 5:39 AM

08:15 AM EDT, 08/26/2025 (MT Newswires) -- Allarity Therapeutics ( ALLR ) said Tuesday that the US Food and Drug Administration has granted fast-track designation to stenoparib, the company's investigational treatment for patients with advanced ovarian cancer.

Shares of the company rose more than 36% in recent Tuesday premarket activity.

The fast track designation enables expedited development and review of drugs that are intended to treat serious conditions and fill an unmet medical need, the company said.

Price: 1.24, Change: +0.32, Percent Change: +33.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved